Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Product Type
- 5.2. Sales Type
- 5.3. Distribution Channel
6. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type
- 6.1. Gums
- 6.2. Patches
- 6.3. Lozenges
- 6.4. Inhalers
- 6.5. Nasal Spray
- 6.6. Sublingual Tablets
- 6.7. Electronic Nicotine Delivery Systems (ENDS)
7. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Type
- 7.1. Over-the-Counter (OTC)
- 7.2. Prescription-Based
8. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 8.1. Retail Pharmacies
- 8.2. Hospital Pharmacies
- 8.3. Online Pharmacies
- 8.4. Supermarkets & Hypermarkets
- 8.5. Convenience Stores
9. Global Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. Middle East & Africa
10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Sales Forecast 2024 to 2034 by Product Type, Sales Type, and Distribution Channel for 30 Countries
18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
19. Company Profiles
- 19.1. Pfizer Inc.
- 19.2. GlaxoSmithKline plc
- 19.3. Johnson & Johnson Services, Inc.
- 19.4. British American Tobacco plc
- 19.5. Altria Group, Inc.
- 19.6. Philip Morris International Inc.
- 19.7. Dr. Reddy's Laboratories Ltd.
- 19.8. Reynolds American Inc. (RAI)
- 19.9. Cipla Ltd.
- 19.10. Haleon
- 19.11. Perrigo Company plc
- 19.12. Aurora Cannabis Inc.
- 19.13. Kure Inc.
- 19.14. Japan Tobacco Inc.
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF